Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Pharmacopeia Drug Discovery, Inc.”

41 pharma patents match "Pharmacopeia Drug Discovery, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 41
Index total 30,257
Page 2 / 2

Quick answer

This filtered view shows 41 pharmaceutical patents matching "Pharmacopeia Drug Discovery, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

41 results for “Pharmacopeia Drug Discovery, Inc.” · 30,257 patents in full index Clear search

  1. US 7074924

    Pyrazolopyrimidines as cyclin dependent kinase inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Jul 11, 2006 · Expires Jul 6, 2026

    granted
  2. US 7067661

    Pyrazolopyrimidines as cyclin dependent kinase inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Jun 27, 2006 · Expires Jun 22, 2026

    granted
  3. US 7037916

    Pyrimidine derivatives as IL-8 receptor antagonists

    Pharmacopeia Drug Discovery, Inc. · Granted May 2, 2006 · Expires Apr 27, 2026

    expired
  4. US 7034056

    Aryl and biaryl compounds having MCH modulatory activity

    Pharmacopeia Drug Discovery, Inc. · Granted Apr 25, 2006 · Expires Apr 20, 2026

    expired
  5. US 6943161

    Pyrimidine and triazine kinase inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Sep 13, 2005 · Expires Sep 8, 2025

    expired
  6. US 6919347

    Bradykinin B1 receptor antagonists

    Pharmacopeia Drug Discovery, Inc. · Granted Jul 19, 2005 · Expires Jul 14, 2025

    expired
  7. US 6903131

    3,4-di-substituted maleimide compounds as CXC chemokine receptor antagonists

    Pharmacopeia Drug Discovery, Inc. · Granted Jun 7, 2005 · Expires Jun 2, 2025

    expired
  8. US 6900213

    Bisaryl derivatives having FSH modulatory activity

    Pharmacopeia Drug Discovery, Inc. · Granted May 31, 2005 · Expires May 26, 2025

    expired
  9. US 6887865

    N-heterocyclic derivatives as NOS inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted May 3, 2005 · Expires Apr 28, 2025

    expired
  10. US 6887889

    Aryl and biaryl piperdines with MCH modulatory activity

    Pharmacopeia Drug Discovery, Inc. · Granted May 3, 2005 · Expires Apr 28, 2025

    expired
  11. US 6878709

    3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists

    Pharmacopeia Drug Discovery, Inc. · Granted Apr 12, 2005 · Expires Apr 7, 2025

    expired
  12. US 6864263

    N-heterocyclic derivatives as NOS inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Mar 8, 2005 · Expires Mar 3, 2025

    expired
  13. US 6864368

    N-heterocyclic derivatives as NOS inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Mar 8, 2005 · Expires Mar 3, 2025

    expired
  14. US 6849739

    N-heterocyclic derivatives as NOS inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Feb 1, 2005 · Expires Jan 27, 2025

    expired
  15. US 6849621

    Piperidine compounds

    Pharmacopeia Drug Discovery, Inc. · Granted Feb 1, 2005 · Expires Jan 27, 2025

    expired
  16. US 6846829

    N-heterocyclic derivatives as NOS inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Jan 25, 2005 · Expires Jan 20, 2025

    expired
  17. US 6841674

    N-heterocyclic derivatives as NOS inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Jan 11, 2005 · Expires Jan 6, 2025

    expired